Peptide-based immunotherapy in lupus: Where are we now?

In autoimmune rheumatic diseases, immune hyperactivity and chronic inflammation associate with immune dysregulation and the breakdown of immune self-tolerance. A continued, unresolved imbalance between effector and regulatory immune responses further exacerbates inflammation that ultimately causes t...

Descripción completa

Detalles Bibliográficos
Autores principales: P. Singh, Ram, S. Bischoff, David, S Singh, Satendra, H. Hahn, Bevra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538607/
https://www.ncbi.nlm.nih.gov/pubmed/37781681
http://dx.doi.org/10.2478/rir-2023-0020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538607/
https://www.ncbi.nlm.nih.gov/pubmed/37781681
http://dx.doi.org/10.2478/rir-2023-0020

Ejemplares similares